Technical Analysis for GSS - Genetic Signatures Ltd  

Grade Last Price % Change Price Change
A 0.700 0.00% 0.000
GSS closed unchanged on Wednesday, April 17, 2024, on 0 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Flat

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
20 DMA Support Bullish 0.00%
Outside Day Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Gapped Down Weakness 0.00%
Overbought Stochastic Strength 0.72%
Gapped Down Weakness 0.72%
20 DMA Support Bullish 1.45%

   Recent Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Genetic Signatures Ltd   Description

Genetic Signatures Limited is a molecular diagnostics company. The Company is engaged in the research and commercialization of identifying individual genetic signature to identify diseases and disabilities, and the sale of associated products into diagnostic and research market place. It is focused on the development and commercialization of its platform technology, 3Base. The Company has a suite of polymerase chain reaction (PCR)-based products for the detection of infectious diseases under the EasyScreen brand. Its product portfolio includes EasyScreen detection kits and MethylEasy research kits. The Company's 3base technology forms the basis of its EasyScreen Pathogen Detection Kits. Its EasyScreen products provide hospital and pathology laboratories with the molecular tools to screen for an array of infectious pathogens. Its MethylEasy research kits include Methyl Easy Xceed, which is a bisulfite modification research kit for the detection of methylation patterns in genes.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Chemistry Biotechnology Disease Hospital Diseases Biology Nature Platform Technology Pathology Infectious Diseases Easy Molecular Diagnostics Infectious Disease Laboratory Techniques Molecular Biology Polymerase Chain Reaction

Is GSS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 0.85
52 Week Low 0.38
Average Volume 73,841
200-Day Moving Average 0.534
50-Day Moving Average 0.606
20-Day Moving Average 0.678
10-Day Moving Average 0.697
Average True Range 0.021
RSI (14) 65.99
ADX 30.36
+DI 26.896
-DI 21.436
Chandelier Exit (Long, 3 ATRs) 0.636
Chandelier Exit (Short, 3 ATRs) 0.684
Upper Bollinger Bands 0.725
Lower Bollinger Band 0.630
Percent B (%b) 0.74
BandWidth 14.022
MACD Line 0.024
MACD Signal Line 0.028
MACD Histogram -0.0035
Fundamentals Value
Market Cap 100.01 Million
Num Shares 143 Million
EPS -0.03
Price-to-Earnings (P/E) Ratio -20.59
Price-to-Sales 19.72
Price-to-Book 5.44
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.715
Resistance 3 (R3) 0.713 0.707 0.713
Resistance 2 (R2) 0.707 0.703 0.708 0.712
Resistance 1 (R1) 0.703 0.700 0.705 0.705 0.711
Pivot Point 0.697 0.697 0.698 0.698 0.697
Support 1 (S1) 0.693 0.693 0.695 0.695 0.689
Support 2 (S2) 0.687 0.690 0.688 0.688
Support 3 (S3) 0.683 0.687 0.688
Support 4 (S4) 0.685